Tape note · Biotech & Health
AI-for-biology name, still early, still on the research list.
Recursion Pharmaceuticals · RXRX · Nasdaq
+8.8%
7.05 · vol 8.6M · from 6.48
AI-for-biology name, still early, still on the research list.
This name is on the tape because of the move, not because it has a full radar file. If we open one, it will say why the company is worth reading beyond today’s percentage.
